Skip to main content

Published works by Fangli Chen

LEX-AR-MEJD2044 · complete body of work · page 1 of 1 · 18 works

Published works

Supreme Court Reverses Federal Circuit in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: A Unanimous Decision for “Skinny Labels” and Generic Drug Competition
The Patent Playbook · June 5, 2026
LEX-WK-53KQBBFB
Supreme Court Hears Oral Argument in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.: Induced Infringement and “Skinny Labels” at a Crossroads
The Patent Playbook · April 30, 2026
LEX-WK-E42RKSQJ
Supreme Court Takes Up <em>Hikma v. Amarin</em>: Induced Infringement and Skinny Labels in the Crosshairs
The Patent Playbook · January 21, 2026
LEX-WK-E3T00PCH
<em>Novo Nordisk v. Mylan</em>: Method of Treatment Claims Must Be Aligned with Label
The Patent Playbook · September 8, 2025
LEX-WK-HT66WHYP
Beyond the Deal: How are Expiring Patents Fueling M&A in the Life Sciences Industry?
The Patent Playbook · April 14, 2025
LEX-WK-E0FXQRZ6
Troubling Trend of “Self” Revocation In the CRISPR Space Continues in Europe
The Patent Playbook · December 17, 2024
LEX-WK-8WG3GTC5
Troubling Trend of “Self” Revocation In the CRISPR Space Continues in Europe
Minding Your Business · December 17, 2024
LEX-WK-MDV0Z36Q
To Be Or Not To Be: Self-Revocation of Seminal European Patents Creates New Uncertainty In CRISPR IP Space
The Patent Playbook · November 11, 2024
LEX-WK-2QHY1225
To Be Or Not To Be: Self-Revocation of Seminal European Patents Creates New Uncertainty In CRISPR IP Space
Minding Your Business · November 11, 2024
LEX-WK-QZCJVVTP
The Broad Impact of <em>Edwards v. Meril</em> on the Safe Harbor Provision
The Patent Playbook · August 27, 2024
LEX-WK-AP0S4A63
The Broad Impact of <em>Edwards v. Meril</em> on the Safe Harbor Provision
Minding Your Business · August 27, 2024
LEX-WK-X9XBRQRN
Duty of Candor Continues Before the PTAB or Does it?
The Patent Playbook · December 1, 2023
LEX-WK-BMQ0J499
Duty of Candor Continues Before the PTAB or Does it?
Minding Your Business · December 1, 2023
LEX-WK-BYDD5W4A
The Supreme Court Kept the Door Open to Genus Claims
The Patent Playbook · May 24, 2023
LEX-WK-XF12WFM8
A Reminder of Doctrine of Equivalents in Biotechnology: Jennewein Biotechnologie GmbH v. International Trade Commission
The Patent Playbook · November 4, 2021
LEX-WK-0584Q29Q
Why Obviousness-type Double Patent Analysis Isn’t Obvious
The Patent Playbook · August 6, 2021
LEX-WK-CBB192ER
A Guiding Light for the Research Safe Harbor and “Research Tools”?
The Patent Playbook · July 7, 2021
LEX-WK-ADPC4YX2
UC Berkeley CRISPR Patent Revoked in Europe Due To Invalid Priority Claim
Minding Your Business · May 24, 2021
LEX-WK-QPYPSMKA